Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Panbela Therapeutics ( (PBLA) ).
On February 12, 2025, Panbela Therapeutics, Inc. announced a reduction in the annual compensation for their CEO and President, Jennifer K. Simpson, and their VP of Finance and CFO, Susan Horvath. Dr. Simpson’s new annual salary is approximately $30,200, while Ms. Horvath’s is $23,150, reflecting a significant adjustment in executive compensation.
More about Panbela Therapeutics
YTD Price Performance: -24.44%
Average Trading Volume: 18,279
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.65M
For a thorough assessment of PBLA stock, go to TipRanks’ Stock Analysis page.
